HCPLive Network
  • AHA 2014
  • Family Practice Recertification
  • Internal Medicine World Report
  • Multiple Sclerosis Peer Exchange Video Series
  • Cardiology Review
  • Physician’s Money Digest
  • Surgical Rounds
Latest Specialty Headlines
Friday, December 19, 2014
By Jeannette Y. Wick, RPh, MBA, FASCP
Atherosclerotic internal carotid artery disease is a major contributor to ischemic stroke. Surgeons use a combination of carotid artery and brain imaging to determine if patients have symptomatic carotid stenosis. However, there remains widespread disagreement on the threshold, timing, and best technical approach to carotid revascularization in symptomatic patients.
Friday, December 19, 2014
By Jeannette Y. Wick, RPh, MBA, FASCP
Slightly more than 6.8 million community-dwelling Americans use assistive devices (eg, canes, walkers, crutches) to help them with mobility and, of these, 1.7 million people use wheelchairs or scooter riders. These Americans at risk for unique musculoskeletal problems, especially rotator cuff injuries.
Friday, December 19, 2014
By Rachel Lutz
The FDA has cleared a blood test that can screen patients, especially black women, for coronary heart disease.
Friday, December 19, 2014
By Rachel Lutz
The chemical compound indazole chloride (Ind-Cl) initiated long lasting relief in mice models of multiple sclerosis.
Friday, December 19, 2014
By Adam Hochron
The US Food and Drug Administration has announced the approval of a new combination treatment for hepatitis C virus.
Friday, December 19, 2014
The flu is starting to tighten its grip on much of the United States, particularly in the South and Midwest, according to a report published in the Dec. 19 issue of the US Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
Friday, December 19, 2014
Half of US states are poorly prepared to prevent, detect, and respond to infectious disease outbreaks. That was the main conclusion of a report issued jointly by the Trust for America's Health and the Robert Wood Johnson Foundation.
Friday, December 19, 2014
Difficulty standing on one leg may indicate that lacunar infarctions or microbleeds have already occurred, which means the risk for more serious strokes is high, the investigators according to research published online Dec. 18 in Stroke.
Friday, December 19, 2014
Prostaglandin analogue eye drops significantly reduce the risk of vision loss in patients with glaucoma, according to a new study published online Dec. 18 in The Lancet.
Friday, December 19, 2014
Traveling through the same US airport gate, one infected passenger transmitted the measles virus to 3 others within a 4-hour time span, illustrating just how easily the virus can spread. These findings were reported in the Dec. 19 issue of the US Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
Friday, December 19, 2014
Predictors have been identified for referral-warranted-retinopathy of prematurity, according to research published online Dec. 18 in JAMA Ophthalmology.
Friday, December 19, 2014
For patients with melanoma arising in head and neck subsites, there is no association between sentinel lymph node biopsy and disease-specific survival, according to research published in the December issue of JAMA Otolaryngology-Head & Neck Surgery.
Email Signup
Breaking News
The US Food and Drug Administration has announced the approval of a new combination treatment for hepatitis C virus.
The US Food and Drug Administration (FDA) approved today Xtoro (finafloxacinotic suspension), a novel drug treatment for acute otitis externa, otherwise known as swimmer’s ear, an infection within the outer ear and ear canal, typically caused by bacteria festered in the ear canal.
Officials at a Swiss hospital today announced they are temporarily halting trials of VSV-ZEBOV, the Ebola vaccine from Merck and NewLink. The trial is being conducted at Hopitaux Universitaires de Geneve. The trials will resume on Jan. 5, 2015. The decision was made after 4 volunteers developed mild joint pain in their hands and feet from 10 to 15 days after being vaccinated. There are 59 volunteers participating in the trial at the Swiss site.
Physician's Money Digest
The intense competition for doctors is creating an environment where hospitals and health systems are compelled to pool their resources if they want to stay competitive
Success is a journey. Having the proper accounting methods established early on in your career will make the journey more enjoyable, although never without challenges.
Product News
The US Food and Drug Administration today approved Merck’s Gardasil 9, a vaccine that offers protection against 5 more types of Human Papillomavirus (HPV) than original Gardasil. In addition to preventing cervical, vulvar, vaginal and anal cancers caused by HPV types 16 and 18 (those prevented by the older version of Gardasil) Gardasil 9 also prevents those cancers caused by HPV strains 31, 33, 45, 52, and 58.
Obizur (Antihemophilic Factor [Recombinant], Porcine Sequence) has been approved to treat acquired hemophilia A (acquired Factor VIII deficiency), a rare, non-inherited form of hemophilia.
The US Food and Drug Administration (FDA) approved Genzyme’s application to include new information about its multiple sclerosis drug teriflunomide (Aubagio) on its label. The new labeling content is efficacy and safety data from two Phase III trials of the drug.
HCPLive Poll
Twitter Advice
Have you ever given medical or financial advice on Twitter?